Resistant Starch, Antioxidant Status and Insulin Resistance
- Conditions
- ObesityOverweight
- Interventions
- Dietary Supplement: Hi-maize resistant starchDietary Supplement: Maltodextrin
- Registration Number
- NCT01992783
- Lead Sponsor
- Urmia University of Medical Sciences
- Brief Summary
The aim of this study is to evaluate whether supplementation with resistant starch improves biomarkers associated with antioxidant status and insulin resistance in subjects with overweight and obesity.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 21
- Overweight and obese adults
- Age: 20-50 years
- weight loss or gain (more than10%) over the past 6 months, or weight loss (more than 5%) over the past 1 month
- pregnancy, lactation or menopause
- History of acute disease or clinical evidence of cancer, acute or chronic inflammatory diseases, cardiovascular disease, renal disease, liver disease, thyroid or endocrine disease
- Gastrointestinal disease of which ingredients found in the study products have adverse effects on that
- Use of antihypertensive, lipid lowering or glucose lowering medications
- Taking antioxidant, vitamin, and/or mineral supplements
- smoking
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Hi-maize resistant starch Hi-maize resistant starch 13.5 g/day Maltodextrin Maltodextrin 13.5 g/day
- Primary Outcome Measures
Name Time Method Antioxidant status 4 weeks Superoxide dismutase (SOD), Plasma malondialdehyde (MDA), Total antioxidant capacity (TAC)
- Secondary Outcome Measures
Name Time Method Anthropometric parameters 4 weeks Height, Weight, Body Mass Index (BMI), Waist circumference
Lipid profile 4 weeks Triglyceride, Total cholesterol, HDL-cholesterol, LDL-cholesterol, Total cholesterol/HDL-cholesterol
Blood pressure 4 weeks Insulin resistance 4 weeks Fasting glucose, Fasting insulin, Insulin resistant (HOMA-IR)